💡 Episode Summary

GLP-1 medications are everywhere—Ozempic, Wegovy, Mounjaro—and the headlines range from miracle to mayhem. So what’s true? And what’s total BS?

In this no-fluff Summer Shorts episode, Beth breaks down the 8 biggest myths about GLP-1s using real research, clinical trial data, and insights from top hormone doctors. If you've ever wondered whether these meds are safe, sustainable, or just hype, this is your clarity moment.

🧠 What You'll Learn:

• Why GLP-1s were never designed as weight-loss drugs
• What the STEP 1 and SURMOUNT-1 trials say about long-term use
• The truth about muscle loss, thyroid cancer, and GI issues
• And why choosing modern medicine doesn’t make you a cheater

🔍 Featured Research & Expert Sources:

• STEP 1 Clinical Trial: Wilding, J.P.H., et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021. DOI:10.1056/NEJMoa2032183
• SURMOUNT-1 Trial: Jastreboff, A.M., et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 2022. DOI:10.1056/NEJMoa2206038
• GLP-1 & Thyroid Risk: Nauck, M.A., et al. "Safety and Efficacy of GLP-1 Receptor Agonists." Diabetes, Obesity & Metabolism, 2022.
• Pancreatitis & Gallbladder Insight: Mayo Clinic & NIH
• Dr. Mary Claire Haver – OB/GYN, author of The New Menopause, emphasizes protein, lifting, and GLP strategy for women 40+
• Dr. Tyna Moore – Naturopathic physician & hormone expert; advocates for microdosing GLP-1s, strength training, and muscle preservation during metabolic therapy

✨ Quote Worth Sharing:"You wouldn’t shame someone for taking insulin. So why shame someone for avoiding dialysis, heart failure, or a lifetime of suffering? GLPs are a tool—not a cheat."🔜 Next Week on Summer Shorts:

We’re talking microdosing GLP-1s—what it is, why it works, and how it might just be the missing link to managing perimenopause and menopause symptoms.

Until then, hydrate, lift heavy, and stop apologizing for taking care of yourself. 💪